Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.
Latest website image capture
Clouds background image

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:53:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the prior government funding/status notices; the revision history is updated accordingly.
    Difference
    0.1%
    Check dated 2026-02-11T05:50:28.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Site-wide notice about a lapse in government funding appears and the page shows Revision: v3.4.1; there are no changes to the study's core content, outcomes, or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T05:54:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary display option and updated revision metadata to v3.4.0, including a No FEAR Act Data notice. Removed the previous QC update label (Last Update Submitted that met QC Criteria), the older No FEAR Act data text, and the prior revision indicator (v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-28T03:51:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:48:26.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations have been reorganized with many new location groupings added (e.g., Brussels Capital, Czech Republic, Kent, Madrid, Valencia, etc.). Several previously listed location groups (e.g., Brussels Capital Locations, BGR Locations, Czech Republic Locations) were removed.
    Difference
    1%
    Check dated 2025-12-23T10:11:30.000Z thumbnail image

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.